Cargando…

Common germ-line polymorphism of C1QA and breast cancer survival

BACKGROUND: A synonymous single nucleotide polymorphism (SNP) rs172378 (A>G, Gly−>Gly) in the complement component C1QA has been proposed to be associated with distant breast cancer metastasis. We previously reported overexpression of this gene to be significantly associated with better progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azzato, E M, Lee, A J X, Teschendorff, A, Ponder, B A J, Pharoah, P, Caldas, C, Maia, A T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856004/ https://www.ncbi.nlm.nih.gov/pubmed/20332777 http://dx.doi.org/10.1038/sj.bjc.6605625

Ejemplares similares

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population
por: Lesueur, F, et al.
Publicado: (2006)

Interactions between genes involved in the antioxidant defence system and breast cancer risk
por: Oestergaard, M Z, et al.
Publicado: (2006)

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours
por: Özdağ, H, et al.
Publicado: (2002)

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer
por: Benusiglio, P R, et al.
Publicado: (2006)

Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort
por: Azzato, Elizabeth M, et al.
Publicado: (2008)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer
por: Barnes, D R, et al.
Publicado: (2013)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

Malignant germ cell tumours of childhood: new associations of genomic imbalance
por: Palmer, R D, et al.
Publicado: (2007)

Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance
por: Jeyapalan, J N, et al.
Publicado: (2011)

Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival
por: Rotunno, M, et al.
Publicado: (2010)

Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells
por: Almstrup, K, et al.
Publicado: (2010)

Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines
por: Letessier, A, et al.
Publicado: (2005)

The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types
por: Forget, M-A, et al.
Publicado: (2007)

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival
por: Einarsdóttir, K, et al.
Publicado: (2009)

Allelotype of 28 human breast cancer cell lines and xenografts
por: Harkes, I C, et al.
Publicado: (2003)

Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations
por: Menzel, H-J, et al.
Publicado: (2004)

A prospective study of neurofibromatosis type 1 cancer incidence in the UK
por: Walker, L, et al.
Publicado: (2006)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group
por: Kweekel, D M, et al.
Publicado: (2008)

Common genetic variants in the 9p21 region and their associations with multiple tumours
por: Gu, F, et al.
Publicado: (2013)

TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival
por: Mu, L, et al.
Publicado: (2008)

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer
por: Tomlinson, I P M, et al.
Publicado: (2010)

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers
por: Osorio, A, et al.
Publicado: (2008)

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
por: Jakubowska, A, et al.
Publicado: (2012)

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

A physical analysis of the Y chromosome shows no additional deletions, other than Gr/Gr, associated with testicular germ cell tumour
por: Linger, R, et al.
Publicado: (2007)

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
por: Ahmed, Mahbubl, et al.
Publicado: (2016)

Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances
por: Timmers, Paul RHJ, et al.
Publicado: (2019)

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers
por: Kadouri, L, et al.
Publicado: (2004)

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels
por: Jesser, C, et al.
Publicado: (2008)

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer
por: Chang-Claude, J, et al.
Publicado: (2009)

Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma
por: Schernhammer, E S, et al.
Publicado: (2006)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients
por: Apessos, A, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_7m71v867grnhc9715bk3sj4tsv